|
1
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li C, Zhang L, Meng G, Wang Q, Lv X, Zhang J and Li J: Circular RNAs: Pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 145:2875–2889. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Xu C, Gao Y, Wang Y, Ding Z, Zhang Y, Shen W, Zheng Y and Wan Y: A novel long non-coding RNA, MSTRG.51053.2 regulates cisplatin resistance by sponging the miR-432-5p in non-small cell lung cancer cells. Front Oncol. 10:215. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun M, He L, Fan Z, Tang R and Du J: Effective treatment of drug-resistant lung cancer via a nanogel capable of reactivating cisplatin and enhancing early apoptosis. Biomaterials. 257:1202522020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidtova S, Kalavska K and Kucerova L: Molecular mechanisms of cisplatin chemoresistance and its circumventing in testicular germ cell tumors. Curr Oncol Rep. 20:882018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu M, Dai X, Zhou H, Zhu J, Zhang H, et al: Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. Mol Cancer. 19:101. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang C, Tan S, Li J, Liu WR, Peng Y and Li W: CircRNAs in lung cancer - Biogenesis, function and clinical implication. Cancer Lett. 492:106–115. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Zhao L and Wang Y: Circular RNA circ_0020123 promotes non-small cell lung cancer progression by sponging miR-590-5p to regulate THBS2. Cancer Cell Int. 20:3872020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong Y, Xu T, Zhong S, Wang B, Zhang H, Wang X, Wang P, Li G and Yang S: Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Life Sci. 239:1169842019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu Z, Gong Q, Yu Y, Zhu J and Li W: Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis. BMC Pulm Med. 20:102020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Zhao H and Zhang L: Identification of the tumor suppressive function of circular RNA FOXO3 in non small cell lung cancer through sponging miR 155. Mol Med Rep. 17:7692–7700. 2018.PubMed/NCBI
|
|
14
|
Smolle E, Leko P, Stacher-Priehse E, Brcic L, El-Heliebi A, Hofmann L, Quehenberger F, Hrzenjak A, Popper HH, Olschewski H, et al: Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer. Mol Oncol. 14:2853–2867. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haque MM and Desai KV: Pathways to endocrine therapy resistance in breast cancer. Front Endocrinol (Lausanne). 10:5732019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong Z, Fu Z, Shi J, Jiang X and Wan H: HtrA1 Down-regulation induces cisplatin resistance in colon cancer by increasing XIAP and Activating PI3K/Akt pathway. Ann Clin Lab Sci. 47:264–270. 2017.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin D, Hua L, Wang J, Liu Y and Li X: Long non-coding RNA DUXAP8 facilitates cell viability, migration, and glycolysis in non-small-cell lung cancer via regulating HK2 and LDHA by inhibition of miR-409-3p. OncoTargets Ther. 13:7111–7123. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo C, Wang H, Jiang H, Qiao L and Wang X: Circ_0011292 enhances paclitaxel resistance in non-small cell lung cancer by regulating miR-379-5p/TRIM65 axis. Cancer Biother Radiopharm. Aug 20–2020.(Epub ahead of print). View Article : Google Scholar
|
|
21
|
Lu M, Xiong H, Xia ZK, Liu B, Wu F, Zhang HX, Hu CH and Liu P: circRACGAP1 promotes non small cell lung cancer proliferation by regulating miR 144 5p/CDKL1 signaling pathway. Cancer Gene Ther. 28:197–211. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song L, Cui Z and Guo X: Comprehensive analysis of circular RNA expression profiles in cisplatin-resistant non-small cell lung cancer cell lines. Acta Biochim Biophys Sin (Shanghai). 52:944–953. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Y, Zheng R, Chen J and Ning D: circRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int. 20:2892020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akins NS, Nielson TC and Le HV: Inhibition of glycolysis and glutaminolysis: An emerging drug discovery approach to combat cancer. Curr Top Med Chem. 18:494–504. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo J, Su Y and Zhang M: Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p. Cancer Cell Int. 20:4072020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Jiang T, Wu C and Zhang Y: circAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. Biotechnol Lett. 42:1123–1135. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou C, Zhao X and Duan S: The role of miR 543 in human cancerous and noncancerous diseases. J Cell Physiol. 236:15–26. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu J, Chen Y, Li X, Miao H, Li R, Chen D and Wen Z: THUMPD3-AS1 is correlated with non-small cell lung cancer and regulates self-renewal through miR-543 and ONECUT2. OncoTargets Ther. 12:9849–9860. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D, Cai L, Tian X and Li W: miR-543 promotes tumorigenesis and angiogenesis in non-small cell lung cancer via modulating metastasis associated protein 1. Mol Med. 26:442020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu G, Zhou J and Dong M: Down regulation of miR 543 expression increases the sensitivity of colorectal cancer cells to 5 Fluorouracil through the PTEN/PI3K/AKT pathway. Biosci Rep. 39:BSR201902492019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma Z, Gu G, Pan W and Chen X: LncRNA PCAT6 accelerates the progression and chemoresistance of cervical cancer through up-regulating ZEB1 by sponging miR-543. OncoTargets Ther. 13:1159–1170. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Khatri S, Yepiskoposyan H, Gallo CA, Tandon P and Plas DR: FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. J Biol Chem. 285:15960–15965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bodur C, Karakas B, Timucin AC, Tezil T and Basaga H: AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins. Mol Carcinog. 55:1584–1597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aldonza MB, Hong JY and Lee SK: Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. Exp Mol Med. 49:e2862017. View Article : Google Scholar : PubMed/NCBI
|
